Browsing by Author Guminski, Alexander

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 30  next >
Issue DateTitleAuthor(s)Citation
2016Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanomaCarlino, Matteo; Fogarty, Gerald; Guminski, Alexander; Hong, Angela; Kefford, Richard (Rick); Liniker, Elizabeth; Lo, Serigne; Long, Georgina; Menzies, Alexander Maxwel; Ramanujam, Sangeetha; Cooper, Adam; Kong, Benjamin; Wang, T. W.; Western Clinical School: Medicine (Westmead); Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Melonoma & Skin Cancer Res. Inst.; The George Institute for Global Health; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma, OncoImmunology, vol.5, 9, 2016,pp 1-7
2008Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian CancerBalleine, Rosemary; Chiew, Yoke-Eng; deFazio, Anna; Guminski, Alexander; Harnett, Paul; Kennedy, Catherine Jane; Lei, Ying; Pryor, Kylie; Rizos, Helen; Scurr, Lyndee; Brand, Alison; Byth, Karen; Sharma, Raghwa; Wain, Gerard V.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Millennium Institute; Medicine Faculty Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer, Clinical Cancer Research, vol.14, 21, 2008,pp 6924-6932
2017Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumabCarlino, Matteo; Guminski, Alexander; Long, Georgina; Menzies, Alexander Maxwel; Park, John; Ramanujam, Sangeetha; Atkinson, V; Eroglu, Z; et al, Various; Johnson, Douglas B; Klein, O; McQuade, J; Shoushtari, A; Tsai, K. K.; Wong, Annie; Western Clinical School: Medicine (Westmead); Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab, Annals of Oncology, vol.28, 2, 2017,pp 368-376
2015Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitorsCarlino, Matteo; Drummond, Martin John; Guminski, Alexander; Kefford, Richard (Rick); Lo, Serigne; Long, Georgina; Lyle, Megan; Menzies, Alexander Maxwel; Scolyer, Richard; Thompson, John; Wilmott, James; Chan, Matthew M K; Western Clinical School: Medicine (Westmead); School of Public Health: Public Health; Medicine Faculty Office; Western Clinical School: Westmead Institute for Medical Res; The George Institute for Global Health; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryClinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors, Cancer, vol.121, 21, 2015,pp 3826-3835
2017Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in MelanomaCarlino, Matteo; Guminski, Alexander; Jakrot, Valerie; Kakavand, Hojabr; Kefford, Richard (Rick); Liniker, Elizabeth; Lo, Serigne; Long, Georgina; Madore, Jason; Menzies, Alexander Maxwel; Saw, Robyn; Scolyer, Richard; Thompson, John; Vilain, Ricardo; Wilmott, James; Cooper, Adam J.; Howle, Julie; Kong, Benjamin; Westmead Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Westmead Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: SurgeryDynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in Melanoma, Clinical Cancer Research, vol.23, 17, 2017,pp 5024-5033
2017Efficacy of anti-PD-1 therapy in patients with melanoma brain metastasesCarlino, Matteo; Drummond, Martin; Guminski, Alexander; Kefford, Richard (Rick); Lo, Serigne; Long, Georgina; Menzies, Alexander Maxwel; Park, John; Rai, Rajat; Andrews, Miles C; Cebon, Jonathan Simon; Haydon, Andrew; Klein, O; McArthur, Grant A.; Mendis, S; Parakh, S; Rowe, Catherine; Wong, Annie; Xu, Wen; Western Clinical School: Medicine (Westmead); School of Public Health: Public Health; Northern Clinical School: Medicine; Western Clinical School: Medicine (Westmead); The George Institute for Global Health; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineEfficacy of anti-PD-1 therapy in patients with melanoma brain metastases, British Journal of Cancer, vol.116, 12, 2017,pp 1558-1563
2013Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution seriesBack, Michael; Eade, Thomas; Guminski, Alexander; Lee, Adrian; Veivers, David; Guo, Linxin; Hanna, Catherine; Johnston, Meredith; Wignall, Andrew; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Medicine Faculty Office; Northern Clinical School: Medicine; Central Clinical School: MedicineIntensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution series, Journal of Medical Imaging and Radiation Oncology, vol.57, 3, 2013,pp 356-363
2014Intra-arterial infusion and chemo-embolization for melanoma liver metastasesGuminski, Alexander; Lodh, Suhrid; Maher, Richard; Medicine Faculty OfficeIntra-arterial infusion and chemo-embolization for melanoma liver metastases, Journal of Surgical Oncology, vol.109, 4, 2014,pp 376-382
2016Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersCarlino, Matteo; Guminski, Alexander; Long, Georgina; Menzies, Alexander Maxwel; Buchbinder, Elizabeth I; et al, Various; Johnson, Douglas B; Khushalani, Nikhil I; Lawrence, Donald; Mudigonda, Tejaswi; Ott, Patrick A; Puzanov, Igor; Sullivan, Ryan; Ye, Fei; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineIpilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders, JAMA Oncology, vol.2, 2, 2016,pp 234-240
2006MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma.Balleine, Rosemary; Chiew, Y; Defazio, Anna; Farrell, Geoffrey; Guminski, Alexander; Harnett, Paul; Tapner, Michael; Webster, Lucy; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Medicine Faculty Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteMRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma., Gynecologic oncology, vol.100,(2),2006,pp 239-246
2017A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapyGuminski, Alexander; Lo, Serigne; Maher, Richard; Menzies, Alexander Maxwel; Ascierto, P; Douraghi-Zadeh, D; Grimaldi, A; Harrington, T; Itchins, Malinda; Oatley, M; Northern Clinical School: Medicine; The George Institute for Global Health; Northern Clinical School: Medicine; Northern Clinical School: MedicineA multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy, Melanoma Research, vol.27, 3, 2017,pp 243-250
2014The nature and management of metastatic melanoma after progression on braf inhibitors: Effects of extended BRAF inhibitionChan, Matthew; Clements, Arthur; Guminski, Alexander; Haydu, Lauren; Kefford, Richard (Rick); Long, Georgina; Lyle, Megan; Menzies, Alexander Maxwel; Azer, Mary W. F.; Klein, Oliver; Northern Clinical School: Melanoma Institute of Australia; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: MedicineThe nature and management of metastatic melanoma after progression on braf inhibitors: Effects of extended BRAF inhibition, Cancer, vol.120, 20, 2014,pp 3142-3153
2015Neutrophil-to-lymphocyte ratio in head and neck cancerBack, Michael; Clarke, Stephen; Eade, Thomas; Guminski, Alexander; Guo, Linxin; Haddad, Carol R; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Medicine Faculty OfficeNeutrophil-to-lymphocyte ratio in head and neck cancer, Journal of Medical Imaging and Radiation Oncology, vol.59, 4, 2015,pp 514-519
2015Nonmelanoma Cutaneous Head and Neck Cancer and Merkel Cell Carcinoma: Current Concepts, Advances,and ControversiesGuminski, Alexander; Veness, Michael; Porceddu, S; Medicine Faculty Office; Western Clinical School: Medicine (Westmead)Nonmelanoma Cutaneous Head and Neck Cancer and Merkel Cell Carcinoma: Current Concepts, Advances,and Controversies, Journal of Clinical Oncology, vol.33, 29, 2015,pp 3338-3345
2009Predicting response to IL-2 therapy for metastatic melanoma.Guminski, Alexander; Thompson, John; Medicine Faculty Office; Central Clinical School: SurgeryPredicting response to IL-2 therapy for metastatic melanoma., Expert Review of Anticancer Therapy: an essential contribution to decision making in cancer care, vol.9, 11,pp 1571-1575
2016Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapyCarlino, Matteo; Guminski, Alexander; Kong, Benjamin; Long, Georgina; Menzies, Alexander Maxwel; Kefford, Richard F.; Liniker, Elizabeth; Ramanujam, Sangeetha; Saunders, Catherine A B; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: Office; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineResidual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy, Pigment Cell & Melanoma Research, vol.29, 5, 2016,pp 572-577
2016Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapyCarlino, Matteo; Guminski, Alexander; Kong, Benjamin; Long, Georgina; Menzies, Alexander Maxwel; Kefford, Richard F.; Liniker, Elizabeth; Ramanujam, Sangeetha; Saunders, Catherine A B; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: Office; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineResidual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy, Pigment Cell & Melanoma Research, vol.29, 5, 2016,pp 572-577
2012Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesGuminski, Alexander; Endo-Munoz, Liliana; Hill, Michelle; Leggatt, Graham; Minchin, Rodney; Saunders, Nicholas; Simpson, Fiona; Thompson, Erik Walter; Medicine Faculty OfficeRole of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives, EMBO Molecular Medicine (Online), vol.4, 8, 2012,pp 675-684
2018The Spectrum, Incidence, Kinetics, and Management of Endocrinopathies with Immune Checkpoint Inhibitors for Metastatic MelanomaClifton-Bligh, Roderick; Guminski, Alexander; Long, Georgina; Menzies, Alexander Maxwel; Scott, Emma; Tsang, Venessa Hin Man; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: MedicineThe Spectrum, Incidence, Kinetics, and Management of Endocrinopathies with Immune Checkpoint Inhibitors for Metastatic Melanoma, European Journal of Endocrinology, vol.178, 2, 2018,pp 175-182
2018The Spectrum, Incidence, Kinetics, and Management of Endocrinopathies with Immune Checkpoint Inhibitors for Metastatic MelanomaClifton-Bligh, Roderick; Guminski, Alexander; Long, Georgina; Menzies, Alexander Maxwel; Scott, Emma; Tsang, Venessa Hin Man; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: MedicineThe Spectrum, Incidence, Kinetics, and Management of Endocrinopathies with Immune Checkpoint Inhibitors for Metastatic Melanoma, European Journal of Endocrinology, vol.178, 2, 2018,pp 175-182